Shanghai Junshi Bioscience Co., Ltd.

This study is testing a new drug called JS207, given alone or combined with other medications, for people with advanced non-small cell lung cancer. It's for patients whose cancer has continued to grow despite receiving standard chemotherapy and immunotherapy. The main goal is to …

This study is testing if a new drug called JS107 works better than standard treatments for people with advanced stomach or gastroesophageal junction cancer that has a specific marker called CLDN18.2. It is for patients whose cancer has continued to grow after their first round of…

This study is testing two different drug combinations as first treatment for advanced triple-negative breast cancer that has returned or spread. Researchers want to see if adding the experimental drug JS207 to either 9MW2821 or albumin paclitaxel helps control the cancer better. …